What's New
Effective April 2, 2008 Zelnorm is no longer available to patients in the U.S. More here.
NEW! on aboutIBS.org
New IBS Drug Approval. On April 29, 2008 the FDA approved AMITIZA (lubiprostone) to treat irritable bowel syndrome (IBS) where constipation is the predominant bowel symptom in women 18 years and older. Go »
IFFGD Research Grants Call for Applications. IFFGD is seeking applications from investigators for research related to functional gastrointestinal and motility disorders, and neurogastroenterology. (Closes June 2, 2008) Go »
Funding for Research. (Jan 2008) President's Fiscal Year 2009 budget proposal falls short of preserving research funding at the National Institues of Health (NIH). Senate amendment passed Mar 13, 2008 authorizes increase in funding. Go »
Special Events. View new postings about events and meetings. Go »
Long-Range Research Plan. The National Institutes of Health (NIH) is inviting public comment on long-range research plan draft from the National Commission on Digestive Diseases (Closes March 8, 2008) Go »
Symposium Announcement. The 8th International Symposium on Functional Gastrointestinal Disorders will be held April 17-19, 2009 in Milwaukee, WI. Registration details are available. Go »
Online IBS Study. The Boston University School of Medicine is doing an online study about writing and irritable bowel syndrome (IBS). Take part entirely online. Go »
Fibromyalgia and IBS. A front page article in the New York Times questioned the legitimacy of fibromyalgia and of IBS. View the response from a group of international experts and IFFGD. Go »
Video Corner: The Experts Speak. Watch video interviews from IFFGD Symposium; get the latest information on IBS and other digestive health topics. (Last updated Jan 28, 2008) Go »
Incontinence Prevention. NIH State-of-the-Science Conference Statement recognizes the huge unmet need of those who are affected by incontinence. Go »
Digestive Health Matters Online. Archive copies of our quarterly journal, Digestive Health Matters, are now available online in our Store. (Free to Members - sign in first) Go »
New Discounts for Members. Members now recieve a 100% discount on select IFFGD Learning Center publications in our online Library. Not yet a Member? Join now and enjoy your benefits Go »
Clinical Corner Online for Members. Members may now access answers from digestive health experts to questions about digestive health. Go »
Lotronex. On November 7, 2007 Prometheus Laboratories Inc., a specialty pharmaceutical company signed an agreement with GlaxoSmithKline to acquire exclusive rights to Lotronex (alosetron hydrochloride) Tablets in the United States. Go »
Interpreting Pain in IBS. The human pain experience is a complex neurobiological process. But news stories persist that pain sensitivity in IBS may be psychological. Find out what is wrong with this interpretation. Go »
Publicaciones Disponibles en Español. Todas las opciones para contactar esta organización (IFFGD) sólo están disponibles en inglés. Haga clic aquí »
More from IFFGD
- Want to learn more about a digestive disorder? Visit these IFFGD sites:
| Chronic Constipation | aboutConstipation.org |
| Acid Reflux Disease (GERD) | aboutGERD.org |
| Motility Disorders | aboutGImotility.org |
| About IFFGD | iffgd.org |
| Incontinence or Urgency | aboutIncontinence.org |
| Digestive Disorders in Kids and Teens |
aboutKidsGI.org |
| Digestive Health Research | giResearch.org |